The third Fragment-Based Drug Discovery Down Under Meeting (FBDD-DU3) will be held from the 12th-15th of November 2019 at the Monash Institute of Pharmaceutical Sciences, in Melbourne.
The 2019 conference will bring together an expanding multidisciplinary group of biologists, biochemists, biophysicists, and chemists from academia and industry to hear about the latest techniques and progress in the dynamic and exciting field of fragment-based drug design.
Registration and abstract submission are now closed!
Abstract submissions are closed.
Registration deadline 8th November 2019
- Martin Scanlon (Chair)
- Indu Chandrashekaran
- Menachem Gunzburg
- Christopher MacRaild
- Olga Ilyichova
- Biswaranjan Mohanty
- Bradley Doak
- Narelle Tunstall
Please contact firstname.lastname@example.org if you have any questions